Compile Data Set for Download or QSAR
Report error Found 537 Enz. Inhib. hit(s) with all data for entry = 11606
TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632634(US20230348450, Example 7)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632635(US20230348450, Example 8)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632632(US20230348450, Example 209 | US20230348450, Exampl...)
Affinity DataEC50:  0.0680nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632633(US20230348450, Example 6)
Affinity DataEC50:  0.110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632637(US20230348450, Example 10)
Affinity DataEC50:  0.175nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632630(US20230348450, Example 3)
Affinity DataEC50:  0.320nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632636(US20230348450, Example 9)
Affinity DataEC50:  0.460nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632715(US20230348450, Example 96)
Affinity DataEC50:  10nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632755(US20230348450, Example 137)
Affinity DataEC50:  20nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632795(US20230348450, Example 180)
Affinity DataEC50:  20nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632786(US20230348450, Example 197 | US20230348450, Exampl...)
Affinity DataIC50: 24nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632755(US20230348450, Example 137)
Affinity DataIC50: 28nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632786(US20230348450, Example 197 | US20230348450, Exampl...)
Affinity DataIC50: 28nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632795(US20230348450, Example 180)
Affinity DataIC50: 28nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632757(US20230348450, Example 140)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632800(US20230348450, Example 185)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632843(US20230348450, Example 229)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632766(US20230348450, Example 149)
Affinity DataIC50: 30nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632801(US20230348450, Example 186)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632786(US20230348450, Example 197 | US20230348450, Exampl...)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632835(US20230348450, Example 221)
Affinity DataEC50:  35nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632749(US20230348450, Example 131)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632747(US20230348450, Example 129)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632747(US20230348450, Example 129)
Affinity DataIC50: 40nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632781(US20230348450, Example 182 | US20230348450, Exampl...)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632748(US20230348450, Example 130)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632787(US20230348450, Example 172)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632753(US20230348450, Example 135)
Affinity DataIC50: 40nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632787(US20230348450, Example 172)
Affinity DataIC50: 40nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632771(US20230348450, Example 154)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632769(US20230348450, Example 152)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632749(US20230348450, Example 131)
Affinity DataIC50: 42nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632775(US20230348450, Example 158)
Affinity DataIC50: 44nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632750(US20230348450, Example 132)
Affinity DataIC50: 45nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632742(US20230348450, Example 124)
Affinity DataIC50: 49nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632807(US20230348450, Example 192)
Affinity DataIC50: 49nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632788(US20230348450, Example 173)
Affinity DataIC50: 49nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632750(US20230348450, Example 132)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632742(US20230348450, Example 124)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632764(US20230348450, Example 147)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632813(US20230348450, Example 198)
Affinity DataIC50: 50nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632762(US20230348450, Example 145)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632781(US20230348450, Example 182 | US20230348450, Exampl...)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632763(US20230348450, Example 146)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632751(US20230348450, Example 133)
Affinity DataIC50: 50nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632834(US20230348450, Example 220)
Affinity DataIC50: 52nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632845(US20230348450, Example 231)
Affinity DataIC50: 52nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632842(US20230348450, Example 228)
Affinity DataEC50:  55nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632829(US20230348450, Example 215)
Affinity DataEC50:  55nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632803(US20230348450, Example 188)
Affinity DataIC50: 55nMAssay Description:The following materials were used in this assay: deionized water; Bisphosphoglycerate mutase (BPGM; Standard Buffer: 50 mM Tris, 0.01% Tween 20, pH 7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

Displayed 1 to 50 (of 537 total ) | Next | Last >>
Jump to: